CRISPR/Cas9 Gene Editing of Immune Checkpoint Receptor NKG2A Improves the Efficacy of Primary CD33-CAR-NK Cells Against AML
Nawid Albinger(Goethe University Frankfurt), Evelyn Ullrich(Goethe University Frankfurt), Vinzenz Särchen(Goethe University Frankfurt), Jan‐Henning Klusmann(Goethe University Frankfurt), Michael A. Rieger(Goethe University Frankfurt), Ahmad Al-Ajami(Goethe University Frankfurt), R Bhayadia(Goethe University Frankfurt), Nina Möker(Miltenyi Biotec (Germany)), Jamal Alzubi(University of Freiburg), Tobias Bexte(Goethe University Frankfurt), Olaf Penack(European Society for Blood and Marrow Transplantation), Philipp Wendel(Goethe University Frankfurt), Sarah Mertlitz(Charité - Universitätsmedizin Berlin), Meike Vogler(Goethe University Frankfurt), Toni Cathomen(University of Freiburg), Leon Buchinger(Goethe University Frankfurt), Katharina Imkeller(Goethe University Frankfurt), Alec Geßner(Goethe University Frankfurt)
Cited by 22
Related Papers
Rapid “Open-Source” Engineering of Customized Zinc-Finger Nucleases for Highly Efficient Gene Modification
|Molecular Cell|2008|709
miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia
|Genes & Development|2010|218
BCL2/BCL-XL inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation
|Blood|2011|189
The non-coding RNA landscape of human hematopoiesis and leukemia
|Nature Communications|2017|164